EGFR and glioblastoma: Primary GBM is most common in elderly patients (>60 years) and is characterized by EGFR amplification (40–50%), with a subset carrying the EGFRvIII mutation, PTEN loss, CDKN2A deletion, and TERT promoter mutations, which drive rapid proliferation and invasion [16,17,18,19,20].